干扰素调节因子新剪接异构体IRF7-e的结构及功能

干扰素调节因子7是诱导玉型干扰素表达的最主要的转录因子。寻找IRF7新的剪接异构体,研究其结构及功能,为探索IRF7参与调控玉型干扰素机制的多样性提供基础。通过PCR和Sanger测序获得了IRF7一种新的剪接形式IRF7-e,并通过RACE获取了IRF7-e 基因全长。IRF7-e全长为1994 bp,含5'-UTR 410 bp,3'-UTR 120 bp,开放阅读框1464 bp,编码487个氨基酸的蛋白,预测其等电点为6.659,蛋白分子量为52.8 kD。双荧光素酶报告分析表明过表达IRF7-e能够提高玉型干扰素IFNα和IFNβ启动子的活性,其中对IFNα启动子活性提高了12.18倍,对IFNβ的启动子活性提高了2.99倍。表明IRF7-e可能参与玉型干扰素的调控。     

Repression of Smooth Muscle Differentiation by a Novel High Mobility Group Box-containing Protein,HMG2L1

The molecular mechanisms regulating smooth muscle-specific gene expression during smooth muscle development are poorly understood. Myocardin is an extraordinarily powerful cofactor of serum response factor (SRF) that stimulates expression of smooth muscle-specific genes. In an effort to search for proteins that regulate myocardin function, we identified a novel HMG box-containing protein HMG2L1 (high mobility group 2 like 1). We found that HMG2L1 expression is correlated with the smooth muscle cell (SMC) synthetic phenotype. Overexpression of HMG2L1 in SMCs down-regulated smooth muscle marker expression. Conversely, depletion of endogenous HMG2L1 in SMCs increases smooth muscle-specific gene expression. Furthermore, we found HMG2L1 specifically abrogates myocardin-induced activation of smooth muscle-specific genes. By GST pulldown assays, the interaction domains between HMG2L1 and myocardin were mapped to the N termini of each of the proteins. Finally, we demonstrated that HMG2L1 abrogates myocardin function through disrupting its binding to SRF and abolishing SRF-myocardin complex binding to the promoters of smooth muscle-specific genes. This study provides the first evidence of this novel HMG2L1 molecule playing an important role in attenuating smooth muscle differentiation.